Vertex Pharmaceuticals Incorporated (LON:0QZU)
London flag London · Delayed Price · Currency is GBP · Price in USD
416.83
-3.15 (-0.75%)
At close: Oct 29, 2025

Vertex Pharmaceuticals Market Cap

Vertex Pharmaceuticals has a market cap or net worth of 80.8 billion as of October 30, 2025. Its market cap has decreased by -15.72% in one year.

Market Cap
80.80B
Enterprise Value
72.87B
Revenue
8.33B
Ranking
n/a
PE Ratio
30.43
Stock Price
416.83

Market Cap Chart

Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 51.21M to 80.80B, an increase of 157,683.22%. That is a compound annual growth rate of 23.95%.

History

DateMarket Cap% Change
Oct 29, 202580.80B-2.46%
Dec 31, 202482.84B0.64%
Dec 29, 202382.31B33.80%
Dec 30, 202261.52B49.20%
Dec 31, 202141.23B-8.40%
Dec 31, 202045.01B5.89%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
AstraZeneca194.77B
GSK plc70.40B
Haleon30.72B
Smith & Nephew11.60B
ConvaTec Group4.82B
Hikma Pharmaceuticals4.04B
HUTCHMED (China)1.88B
Genus1.68B
Market Cap Rankings